상세 보기
- Lee, Sung Jong;
- Yoo, Ji Geun;
- Kim, Jin Hwi;
- Park, Jeong-Yeol;
- Lee, Jung-Yun;
- ... Lee, Yoo-Young;
- 외 1명
WEB OF SCIENCE
7SCOPUS
11초록
This review summarized the results of clinical trials in 2024 that were believed to have a significant impact on clinical practice in the field of gynecologic oncology. The SHAPE trial, INTERLACE and KEYNOTE-A18 trials, and BEATcc and COMPASSION-16 trials were included in early-stage, locally advanced, and recurrent/metastatic cervical cancer, respectively. For uterine corpus cancer, updated survival data of the four trials (NRG-GY018, RUBY, AtTEnd, DUO-E) for endometrial cancer and the first survival data of LMS-04 trial for leiomyosarcoma were described. For ovarian cancer, the final overall survival results of PRIMA study were followed by DUO-O, ATHENA-combo, and FIRST-ENGOT-OV44 trial in different disease conditions. Finally, the results of DESTINY-PanTumor02, a basket trial of trastuzumab deruxtecan, were briefly addressed.
키워드
- 제목
- Gynecologic oncology in 2024: breakthrough trials and evolving treatment strategies for cervical, uterine corpus, and ovarian cancers
- 저자
- Lee, Sung Jong; Yoo, Ji Geun; Kim, Jin Hwi; Park, Jeong-Yeol; Lee, Jung-Yun; Lee, Yoo-Young; Suh, Dong Hoon
- 발행일
- 2025-01
- 유형
- Article
- 권
- 36
- 호
- 1
- 페이지
- 1 ~ 15